FF11-0230 Screening compound: 4-{[3-(3-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine

FF11-0230 Screening compound: 4-{[3-(3-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine
FF11-0230 Screening compound: 4-{[3-(3-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound FF11-0230
4-{[3-(3-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

FF11-0230

Molecular Formula

C14H16FN3O (C14 H16 FN3 O)

Compound Name

4-{[3-(3-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine

IUPAC name

4-{[3-(3-fluorophenyl)-124-oxadiazol-5-yl]methyl}piperidine

SMILES

Fc1cc(-c2noc(CC3CCNCC3)n2)ccc1

InChI

InChI=1S/C14H16FN3O/c15-12-3-1-2-11(9-12)14-17-13(19-18-14)8-10-4-6-16-7-5-10/h1-3,9-10,16H,4-8H2

InChI Key

KYAZEVRORJVNSR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD16874869

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

261.3

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

2.263

Distribution Coefficient, logD

-0.945

Water Solubility, LogSw

-2.71

Polar Surface Area

43.463

Acid Dissociation Constant (pKa)

26.01

Base Dissociation Constant (pKb)

10.61

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.86

FF11-0230 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

3D-Fragment Library (4274 compounds)

CNS BBB Library (22607 compounds)

CNS MPO Library (28609 compounds)

GABA Library (7115 compounds)

Soluble Diversity Library (15920 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • 3D
  • Fragments
Therapeutical areas:
  • Nervous system
  • Nervous system
  • Eye
  • Nervous system
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with FF11-0230 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound FF11-0230?
Check Price and Availability of FF11-0230, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of FF11-0230 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for FF11-0230
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for FF11-0230
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of FF11-0230 available by request